SCHEMBL18258559

SCHEMBL18258559

CC/C=C\C/C=C\CC(O)CC/C=C\CCCCCCC(=O)O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFKB1 P19838 1/20 0.78
▸ NFKB2 Q00653 1/20 0.78
▸ RELA Q04206 1/20 0.78
▸ ALDH1A1 P00352 9/20 0.72
▸ F7 P08709 7/20 0.72
▸ F3 P13726 7/20 0.72
▸ FFAR1 O14842 6/20 0.72
▸ PPARG P37231 6/20 0.72
▸ CYP19A1 P11511 5/20 0.72
▸ PPARD Q03181 5/20 0.72
▸ PPARA Q07869 5/20 0.72
▸ PTGS1 P23219 4/20 0.72
▸ OXER1 Q8TDS5 4/20 0.72
▸ FFAR4 Q5NUL3 3/20 0.72
▸ MAPT P10636 3/20 0.72
▸ KMT2A Q03164 2/20 0.72
▸ KDM4E B2RXH2 2/20 0.72
▸ LMNA P02545 2/20 0.72
▸ CYP3A4 P08684 2/20 0.72
▸ HPGD P15428 2/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18258562 1.00 NFKB1 (0.78) NFKB1NFKB2RELAALDH1A1F7
SCHEMBL16681498 0.99 NFKB1 (0.80) NFKB1NFKB2RELAALDH1A1F7
SCHEMBL18258565 0.99 NFKB1 (0.80) NFKB1NFKB2RELAALDH1A1F7
SCHEMBL6703071 0.96 FFAR1 (0.74) NFKB1NFKB2RELAALDH1A1F7
SCHEMBL6703076 0.96 FFAR1 (0.74) NFKB1NFKB2RELAALDH1A1F7
SCHEMBL15202866 0.96 FFAR1 (0.74) NFKB1NFKB2RELAALDH1A1F7
SCHEMBL400772 0.96 FFAR1 (0.74) NFKB1NFKB2RELAALDH1A1F7
SCHEMBL18258566 0.96 FFAR1 (0.74) NFKB1NFKB2RELAALDH1A1F7
SCHEMBL2290578 0.96 FFAR1 (0.74) NFKB1NFKB2RELAALDH1A1F7
SCHEMBL2293758 0.96 FFAR1 (0.74) NFKB1NFKB2RELAALDH1A1F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3677686-B1 HYDROXYLATED FATTY ACID MULTIMERS AND PRODUCTION METHOD THEREOF UNIV KYOTO (JP) 2023-06-07 — — EP claimed
EP-3098313-B1 METHOD FOR PRODUCING RARE FATTY ACID USING NOVEL ENZYME, AND NOVEL RARE FATTY ACID UNIV KYOTO (JP) 2022-01-05 — — EP claimed
US-11130974-B2 Hydroxylated fatty acid homopolymer and production method thereof KYOTO UNIVERSITY (JP) 2021-09-28 — — US claimed
US-20210285020-A1 METHOD FOR PRODUCING RARE FATTY ACID USING NOVEL ENZYME, AND NOVEL RARE FATTY ACID KYOTO UNIVERSITY (JP) 2021-09-16 — — US claimed
US-20210236448-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID KYOTO UNIVERSITY (JP) 2021-08-05 — — US claimed
US-10952983-B2 Metabolism-improving agent comprising rare fatty acid KYOTO UNIVERSITY (JP) 2021-03-23 — — US claimed
US-20210079432-A1 HYDROXYLATED FATTY ACID HOMOPOLYMER AND PRODUCTION METHOD THEREOF KYOTO UNIVERSITY (JP) 2021-03-18 — — US claimed
US-20210069141-A1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID KYOTO UNIVERSITY (JP) 2021-03-11 — — US claimed
EP-3677686-A1 HYDROXYLATED FATTY ACID HOMOPOLYMER AND PRODUCTION METHOD THEREOF Kyoto University (JP) 2020-07-08 — — EP claimed
EP-3097910-B1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID UNIV KYOTO (JP) 2020-05-13 — — EP claimed
US-20200101036-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID KYOTO UNIVERSITY (JP) 2020-04-02 — — US claimed
US-20190256876-A1 METHOD FOR PRODUCING RARE FATTY ACID USING NOVEL ENZYME, AND NOVEL RARE FATTY ACID KYOTO UNIVERSITY (JP) 2019-08-22 — — US claimed
US-20170022526-A1 METHOD FOR PRODUCING RARE FATTY ACID USING NOVEL ENZYME, AND NOVEL RARE FATTY ACID KYOTO UNIVERSITY (JP) 2017-01-26 — — US claimed
US-20170007564-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID KYOTO UNIVERSITY (JP) 2017-01-12 — — US claimed
US-20170000752-A1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID KYOTO UNIVERSITY (JP) 2017-01-05 — — US claimed
EP-3098313-A1 METHOD FOR PRODUCING RARE FATTY ACID USING NOVEL ENZYME, AND NOVEL RARE FATTY ACID Kyoto University (JP) 2016-11-30 — — EP claimed
EP-3097911-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID Kyoto University (JP) 2016-11-30 — — EP claimed
EP-3097910-A1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID Kyoto University (JP) 2016-11-30 — — EP claimed
EP-3097911-B1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID UNIV KYOTO (JP) 2024-05-22 — — EP disclosed
EP-3098313-A1 METHOD FOR PRODUCING RARE FATTY ACID USING NOVEL ENZYME, AND NOVEL RARE FATTY ACID Kyoto University (JP) 2016-11-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200101036-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID FASN, ELOVL1, FADS1 NFKB1 3890/4885NFKB2 4168/4885RELA 4288/4885
US-10952983-B2 Metabolism-improving agent comprising rare fatty acid FASN, ELOVL1, FADS1 NFKB1 3890/4885NFKB2 4168/4885RELA 4288/4885
US-20170007564-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID ELOVL1, FASN, FADS1 NFKB1 3616/4885NFKB2 3973/4885RELA 4275/4885
US-20210285020-A1 METHOD FOR PRODUCING RARE FATTY ACID USING NOVEL ENZYME, AND NOVEL RARE FATTY ACID FADS2, FASN, ELOVL1 NFKB1 4607/4885NFKB2 4743/4885RELA 4600/4885
US-20210236448-A1 METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID FASN, ELOVL1, FADS1 NFKB1 3890/4885NFKB2 4168/4885RELA 4288/4885
US-20210079432-A1 HYDROXYLATED FATTY ACID HOMOPOLYMER AND PRODUCTION METHOD THEREOF FASN, SCD, SCD5 NFKB1 2407/4885NFKB2 2511/4885RELA 2107/4885
US-20210069141-A1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID ELOVL1, ELOVL5, ELOVL3 NFKB1 167/4885NFKB2 245/4885RELA 203/4885
US-20170000752-A1 ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID ELOVL1, ELOVL5, ELOVL3 NFKB1 167/4885NFKB2 245/4885RELA 203/4885
US-11130974-B2 Hydroxylated fatty acid homopolymer and production method thereof FASN, SCD, SCD5 NFKB1 2407/4885NFKB2 2511/4885RELA 2107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback